Author

Min Wu

Institution: Innovent Biologics (China)

Observed institution: Innovent Biologics (China)

ORCID: 0000-0002-3301-990X

Observed ORCID: 0000-0002-3301-990X

OpenAlex ID: A5137194624

Impact of IBI3017, an innovative bispecific anti-Trop2 and B7H3 antibody-drug conjugate, on anti-tumor efficacy in a wide range of tumors.

2026 · Bo Wang, Bin Li, et al. · Journal of Clinical Oncology

Author response for "Novel FLCN Mutations in Birt–Hogg–Dubé Patients and Potential Intervention of FLCN mRNA"

2026 · Wenxue Bai, Mengyao Guo, et al. · Publons reviews and discussion

Author response for "Novel FLCN Mutations in Birt–Hogg–Dubé Patients and Potential Intervention of FLCN mRNA"

2026 · Wenxue Bai, Mengyao Guo, et al. · Publons reviews and discussion

Works count: 3

Citation count:

H-index:

I10-index: